Savior Lifetec Corporation (TPEX:4167)

Market Cap	6.54B
Revenue (ttm)	1.26B
Net Income (ttm)	179.84M
Shares Out	317.40M
EPS (ttm)	0.53
PE Ratio	38.58
Forward PE	n/a
Dividend	0.09 (0.41%)
Ex-Dividend Date	n/a

Volume	440,886
Average Volume	663,620
Open	20.60
Previous Close	20.60
Day's Range	20.55 - 20.90
52-Week Range	18.10 - 27.80
Beta	0.54
RSI	49.20
Earnings Date	Mar 12, 2025

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Miaoli County, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 384
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4167

Financial Performance

In 2023, Savior Lifetec's revenue was 1.05 billion, a decrease of -17.02% compared to the previous year's 1.27 billion. Earnings were 30.03 million, a decrease of -17.47%.